3rd Quarter - Report
THE DUBERSTEIN GROUP INC. for PHRMA INC.
Client
Income
$100,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Medicare/Medicaid MMM
Impact of fiscal deficit, including continuing resolution and debt limit extension on Medicare Part D - HJRes 59 - Continuing Appropriations Resolution, 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Pharmacy PHA
Pharmaceutical issues, including Track and Trace - HR 1919, Safeguarding America's Pharmaceuticals Act of 2013; HR 3204, Drug Quality and Security Act; S 957, Drug Supply Chain Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL P MEYER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.